Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
2.020
-0.100 (-4.72%)
At close: Dec 16, 2025, 4:00 PM EST
2.030
+0.010 (0.50%)
Pre-market: Dec 17, 2025, 8:41 AM EST
PACB Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$2.08
Upside
+2.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $1.5 → $2 | Hold | Maintains | $1.5 → $2 | -0.99% | Dec 15, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.5 → $2 | Hold | Maintains | $1.5 → $2 | -0.99% | Nov 11, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $1.8 → $2 | Buy | Maintains | $1.8 → $2 | -0.99% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.25 → $1.5 | Hold | Maintains | $1.25 → $1.5 | -25.74% | Aug 11, 2025 |
| Barclays | Barclays | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | -25.74% | Jun 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -38.12% | May 15, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $1.8 | Buy | Reiterates | $1.8 | -10.89% | May 15, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +48.51% | Apr 10, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $6 → $2 | Buy | Maintains | $6 → $2 | -0.99% | Mar 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2.5 → $2 | Hold | Reiterates | $2.5 → $2 | -0.99% | Feb 20, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | -25.74% | Feb 18, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +23.76% | Feb 18, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +23.76% | Feb 14, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $2.25 → $1.75 | Hold | Maintains | $2.25 → $1.75 | -13.37% | Jan 23, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | -0.99% | Nov 11, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +197.03% | Nov 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.